Risk of fracture in patients with nonvalvular atrial fibrillation initiating direct oral anticoagulants versus vitamin K antagonists

被引:0
|
作者
He, Na [1 ,2 ,3 ]
Dell'Aniello, Sophie [2 ]
Zhai, Suodi [1 ]
Suissa, Samy [2 ,3 ]
Renoux, Christel [2 ,3 ,4 ]
机构
[1] Peking Univ Third Hosp, Dept Pharm, Beijing, Peoples R China
[2] Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ, Canada
[3] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[4] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
3928
引用
收藏
页码:581 / 581
页数:1
相关论文
共 50 条
  • [31] DIRECT ORAL ANTICOAGULANTS AND THE INCIDENCE OF DEMENTIA IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Rahman, A.
    Johnson, K.
    Michaud, J.
    Moodie, E.
    Brophy, J.
    Boivin, J. -F.
    Renoux, C.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 115 - 116
  • [32] Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
    Gao, Xinxing
    Huang, Donghua
    Hu, Yuting
    Chen, Yuanyuan
    Zhang, Haidong
    Liu, Fuwei
    Luo, Jun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [33] Cerebral thromboembolic risk in atrial fibrillation ablation: a direct comparison of vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants
    Petzl, Adrian
    Derndorfer, Michael
    Kollias, Georgios
    Moroka, Kgomotso
    Aichinger, Josef
    Puererfellner, Helmut
    Martinek, Martin
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 60 (01) : 147 - 154
  • [34] Cerebral thromboembolic risk in atrial fibrillation ablation: a direct comparison of vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants
    Adrian Petzl
    Michael Derndorfer
    Georgios Kollias
    Kgomotso Moroka
    Josef Aichinger
    Helmut Pürerfellner
    Martin Martinek
    Journal of Interventional Cardiac Electrophysiology, 2021, 60 : 147 - 154
  • [35] Vitamin K Antagonists Versus Novel Oral Anticoagulants for Elective Electrical Cardioversion of Atrial Fibrillation
    Tint, Diana
    Petris, Antoniu O.
    Pop, Ioana
    Melnic, Rimma
    Ignat, Andreea-Mihaela
    Rogozea, Liliana M.
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E553 - E558
  • [36] Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
    Chen, Sean T.
    Patel, Manesh R.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 514 - 523
  • [37] Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis
    Saurabh Gupta
    Kevin J. Um
    Arjun Pandey
    William F. McIntyre
    Marina Ivanova
    Yasamin Allahverdi
    Parisa Agahi
    Feny Pandya
    Ana Lopez
    Amrit Sachdeva
    Richard P. Whitlock
    Emilie P. Belley-Cote
    Cardiovascular Drugs and Therapy, 2019, 33 : 339 - 352
  • [38] COMPARISON OF DIRECT ORAL ANTICOAGULANTS VERSUS VITAMIN K ANTAGONISTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE SETTING OF HYPERTROPHIC CARDIOMYOPATHY: A META-ANALYSIS
    Lozier, Matthew R.
    Sanchez, Alexandra
    Escolar, Esteban
    Lee, John
    Font, Vicente
    Donath, Elie
    Albuquerque, Felipe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 480 - 480
  • [39] Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis
    Gupta, Saurabh
    Um, Kevin J.
    Pandey, Arjun
    McIntyre, William F.
    Ivanova, Marina
    Allahverdi, Yasamin
    Agahi, Parisa
    Pandya, Feny
    Lopez, Ana
    Sachdeva, Amrit
    Whitlock, Richard P.
    Belley-Cote, Emilie P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (03) : 339 - 352
  • [40] Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis
    Tong Hu
    Yi-Han Li
    Wen-Qiang Han
    Kellina Maduray
    Tong-Shuai Chen
    Li Hao
    Jing-Quan Zhong
    American Journal of Cardiovascular Drugs, 2023, 23 : 683 - 694